BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maslov DV, Simenson V, Jain S, Badari A. COVID-19 and Cold Agglutinin Hemolytic Anemia. TH Open 2020;4:e175-7. [PMID: 32844144 DOI: 10.1055/s-0040-1715791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmadnejad M, Mosleh M, Ferdowsi S, Mohammadi S, Eshghi P, Oodi A. Cold Agglutinin Associated With COVID-19 Infection in a Thalassemia Patient with Multiple Alloantibodies: A Case of Cold Hemagglutinin Disease (CAD) with Complex Antibody Detection. Hematol Transfus Cell Ther 2021. [PMID: 34056547 DOI: 10.1016/j.htct.2021.04.005] [Reference Citation Analysis]
2 Tsukamoto Y, Umeda M, Muto Y, Sugimoto T, Yamauchi M, Ando K, Ariyoshi K. Severe Anemia Due to Cold Agglutinin Syndrome in a COVID-19 Patient with IgM Monoclonal Gammopathy of Undetermined Significance Successfully Treated with Corticosteroids. Intern Med 2022;61:1789-93. [PMID: 35342131 DOI: 10.2169/internalmedicine.8647-21] [Reference Citation Analysis]
3 Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol 2021;33:155-62. [PMID: 33332890 DOI: 10.1097/BOR.0000000000000776] [Cited by in Crossref: 46] [Cited by in F6Publishing: 24] [Article Influence: 46.0] [Reference Citation Analysis]
4 Ahmed Y, Khandelwal A, Walker L. Cold agglutinin disease and COVID-19 requiring therapeutic plasma exchange. BMJ Case Rep 2021;14:e244227. [PMID: 34312140 DOI: 10.1136/bcr-2021-244227] [Reference Citation Analysis]
5 Moody R, Wilson K, Flanagan KL, Jaworowski A, Plebanski M. Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Int J Mol Sci 2021;22:8965. [PMID: 34445670 DOI: 10.3390/ijms22168965] [Reference Citation Analysis]
6 Fattizzo B, Pasquale R, Bellani V, Barcellini W, Kulasekararaj AG. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature. Front Immunol 2021;12:791429. [PMID: 34899761 DOI: 10.3389/fimmu.2021.791429] [Reference Citation Analysis]
7 Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Batiha GE. Hemolytic anemia in COVID-19. Ann Hematol 2022. [PMID: 35802164 DOI: 10.1007/s00277-022-04907-7] [Reference Citation Analysis]
8 Batista CM, Foti L. Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives. Int Immunopharmacol 2021;99:108036. [PMID: 34371330 DOI: 10.1016/j.intimp.2021.108036] [Reference Citation Analysis]
9 Tang KT, Hsu BC, Chen DY. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review. Front Immunol 2021;12:645013. [PMID: 33777042 DOI: 10.3389/fimmu.2021.645013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Sezen M, Yildiz A, Yavuz M, Dilek K, Güllülü M, Oruç A, Aydin MF, Ersoy A. Acute Tubular Necrosis Associated with Autoimmune Hemolytic Anemia due to Acute Gastroenteritis. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.877028] [Reference Citation Analysis]
11 Jacobs JW, Booth GS. COVID-19 and Immune-Mediated RBC Destruction. Am J Clin Pathol 2022;157:844-51. [PMID: 34919640 DOI: 10.1093/ajcp/aqab210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
12 Taherifard E, Taherifard E, Movahed H, Mousavi MR. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology 2021;26:225-39. [PMID: 33594951 DOI: 10.1080/16078454.2021.1881225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Barcellini W, Giannotta JA, Fattizzo B. Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature. Front Immunol 2020;11:609198. [PMID: 33574816 DOI: 10.3389/fimmu.2020.609198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Shah S, Padrnos L. Complications of Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2021.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun 2021;117:102592. [PMID: 33401171 DOI: 10.1016/j.jaut.2020.102592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
16 Giannotta JA, Fattizzo B, Cavallaro F, Barcellini W. Infectious Complications in Autoimmune Hemolytic Anemia. J Clin Med 2021;10:E164. [PMID: 33466516 DOI: 10.3390/jcm10010164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]